Agios Pharmaceuticals, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC AGIO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

106,996

Value ($000)

2,912

Weight

0.0%

2013 Q4 - 2025 Q4 (26 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	2,912	0.0%	106,996	12/31/2025
2025 Q3	11/14/2025	4,290	0.0%	106,875	9/30/2025
2025 Q2	8/14/2025	7,231	0.0%	217,402	6/30/2025
2025 Q1	5/19/2025	4,315	0.0%	147,276	3/31/2025
2024 Q4	2/14/2025	4,036	0.0%	122,835	12/31/2024
2024 Q3	11/14/2024	5,031	0.0%	113,229	9/30/2024
2024 Q2	8/14/2024	5,410	0.0%	125,470	6/30/2024
2024 Q1	5/15/2024	1,388	0.0%	47,461	3/31/2024
2023 Q4	2/14/2024	1,057	0.0%	47,461	12/31/2023
2023 Q3	11/13/2023	1,175	0.0%	47,461	9/30/2023
2023 Q2	8/11/2023	5,755	0.0%	250,534	6/30/2023
2023 Q1	5/15/2023	5,755	0.0%	250,534	3/31/2023
2022 Q4	2/14/2023	11,437	0.0%	407,309	12/31/2022
2022 Q3	11/14/2022	12,990	0.0%	459,345	9/30/2022
2022 Q2	8/12/2022	10,553	0.0%	476,013	6/30/2022
2022 Q1	5/16/2022	1,883	0.0%	64,701	3/31/2022
2021 Q4	2/14/2022	2,127	0.0%	64,701	12/31/2021
2021 Q3	11/15/2021	3,056	0.0%	66,227	9/30/2021
2021 Q2	8/16/2021	3,984	0.0%	72,294	6/30/2021
2021 Q1	5/14/2021	4,923	0.0%	95,335	3/31/2021
2020 Q4	3/1/2021	3,970	0.0%	91,616	12/31/2020
2020 Q3	11/13/2020	2,677	0.0%	76,495	9/30/2020
2020 Q2	8/14/2020	4,178	0.0%	78,120	6/30/2020
2020 Q1	5/15/2020	15,960	0.0%	449,827	3/31/2020
2019 Q4	2/14/2020	22,914	0.0%	479,882	12/31/2019
2013 Q4	1/31/2014	2,606	0.0%	108,800	12/31/2013